Trial Profile
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-T11 and Japan Adult Leukemia Study Group (JALSG) T-ALL-211-U ALL-T11: A Multi-Center Phase II Study in Children and Adolescence with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2022
Price :
$35
*
At a glance
- Drugs Nelarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 14 Dec 2021 Results (n=364) presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 18 Jul 2018 Planned End Date changed from 1 Nov 2017 to 30 Nov 2020.
- 09 Dec 2011 New trial record